276 related articles for article (PubMed ID: 35277933)
21. Ontogeny of hypothalamic glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in mice.
Laryea G; Arnett M; Muglia LJ
Stress; 2015; 18(4):400-7. PubMed ID: 26068518
[TBL] [Abstract][Full Text] [Related]
22. The effects of high fat diet on the basal activity of the hypothalamus-pituitary-adrenal axis in mice.
Auvinen HE; Romijn JA; Biermasz NR; Pijl H; Havekes LM; Smit JW; Rensen PC; Pereira AM
J Endocrinol; 2012 Aug; 214(2):191-7. PubMed ID: 22619233
[TBL] [Abstract][Full Text] [Related]
23. Corticotroph isolation from Pomc-eGFP mice reveals sustained transcriptional dysregulation characterising a mouse model of glucocorticoid-induced suppression of the hypothalamus-pituitary-adrenal axis.
Duncan PJ; McClafferty H; Nolan O; Ding Q; Homer NZM; Le Tissier P; Walker BR; Shipston MJ; Romanò N; Chambers TJG
J Neuroendocrinol; 2022 Jul; 34(7):e13165. PubMed ID: 35833423
[TBL] [Abstract][Full Text] [Related]
24. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
[TBL] [Abstract][Full Text] [Related]
26. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
27. Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.
Laryea G; Muglia L; Arnett M; Muglia LJ
Front Neuroendocrinol; 2015 Jan; 36():150-64. PubMed ID: 25256348
[TBL] [Abstract][Full Text] [Related]
28. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
Ginsberg AB; Campeau S; Day HE; Spencer RL
J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
[TBL] [Abstract][Full Text] [Related]
29. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
[TBL] [Abstract][Full Text] [Related]
30. Activation of Akt-mTORC1 signalling reverts cancer-dependent muscle wasting.
Geremia A; Sartori R; Baraldo M; Nogara L; Balmaceda V; Dumitras GA; Ciciliot S; Scalabrin M; Nolte H; Blaauw B
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):648-661. PubMed ID: 34741441
[TBL] [Abstract][Full Text] [Related]
31. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
[TBL] [Abstract][Full Text] [Related]
32. Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis.
Kariagina A; Zonis S; Afkhami M; Romanenko D; Chesnokova V
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E857-63. PubMed ID: 15985451
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model.
Petrescu AD; Grant S; Frampton G; Kain J; Hadidi K; Williams E; McMillin M; DeMorrow S
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125588
[TBL] [Abstract][Full Text] [Related]
34. Activation of PPAR-γ reduces HPA axis activity in diabetic rats by up-regulating PI3K expression.
Torres RC; Magalhães NS; E Silva PM; Martins MA; Carvalho VF
Exp Mol Pathol; 2016 Oct; 101(2):290-301. PubMed ID: 27725163
[TBL] [Abstract][Full Text] [Related]
35. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
36. The effects of dexamethasone treatment in early gestation on hypothalamic-pituitary-adrenal responses and gene expression at 7 months of postnatal age in sheep.
Li S; Nitsos I; Polglase GR; Braun T; Moss TJ; Newnham JP; Challis JR
Reprod Sci; 2012 Mar; 19(3):260-70. PubMed ID: 22101239
[TBL] [Abstract][Full Text] [Related]
37. Expression of corticosteroid hormone receptors, prereceptors, and molecular chaperones in hypothalamic-pituitary-adrenal axis and adipose tissue after the administration of growth promoters in veal calves.
Starvaggi Cucuzza L; Divari S; Biolatti B; Cannizzo FT
Domest Anim Endocrinol; 2020 Jul; 72():106473. PubMed ID: 32361423
[TBL] [Abstract][Full Text] [Related]
38. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
Braun TP; Grossberg AJ; Krasnow SM; Levasseur PR; Szumowski M; Zhu XX; Maxson JE; Knoll JG; Barnes AP; Marks DL
FASEB J; 2013 Sep; 27(9):3572-82. PubMed ID: 23733748
[TBL] [Abstract][Full Text] [Related]
39. Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation.
Ladd CO; Huot RL; Thrivikraman KV; Nemeroff CB; Plotsky PM
Biol Psychiatry; 2004 Feb; 55(4):367-75. PubMed ID: 14960289
[TBL] [Abstract][Full Text] [Related]
40. Hypothalamic-pituitary-adrenal axis suppression - The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery.
Kalaria T; Agarwal M; Kaur S; Hughes L; Sharrod-Cole H; Chaudhari R; Gherman-Ciolac C; Chopra R; Okeke V; Ford C; Buch H; Gama R
Ann Clin Biochem; 2020 Nov; 57(6):456-460. PubMed ID: 32961064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
